Search

Your search keyword '"A, Moretta"' showing total 1,258 results

Search Constraints

Start Over You searched for: Author "A, Moretta" Remove constraint Author: "A, Moretta" Language undetermined Remove constraint Language: undetermined
1,258 results on '"A, Moretta"'

Search Results

1. Amphibians and reptiles of Isla Santay (Durán, Ecuador)

3. Heart failure alters diagnostic yield for pulmonary embolism in patients undergoing computed tomography pulmonary angiogram

5. Pemberdayaan Kader Puskesmas Taman Bacaan Sebagai Upaya Mencegah Stunting

6. Voice-specific proper name anomia (‘phonoanomia’) after bilateral temporal hemorrhagic brain lesions

7. Tools in the Era of Multidrug Resistance in Bacteria: Applications for New Antimicrobial Peptides Discovery

10. TYPE II DIABETES MELLITUS AND MANAGEMENT OF ISOLATED HYPERGLYCEMIA: A REVIEW

11. LUMBAR DISK HERNIATION: EVALUATION OF MEDICAL CARE AND PAIN MANAGEMENT AT THE SPECIALTIES HOSPITAL CREHVITAL AMBATO-ECUADOR: RETROSPECTIVE, CROSS-SECTIONAL STUDY, AND ASSESSMENT OF TWO CLINICAL CASES

13. Acute respiratory distress syndrome secondary to Sars-COV-2 infection: treatment with mesenchymal stromal cells (mscs) to prevent pulmonary complications

14. The impact of electronic word-of-mouth management in hotel ecosystem: insights about managers' decision-making process

15. Amphibians and reptiles of Isla Santay (Durán, Ecuador)

18. High-Frequency Low-Tidal-Volume Ventilation Improves Long-Term Outcomes in Atrial Fibrillation Ablation: A Multicenter Prospective Study

20. Familial risk for depression is associated with reduced P300 and late positive potential to affective stimuli and prolonged cardiac deceleration to unpleasant stimuli

21. Supplementary Figures from Nutlin-3a Enhances Natural Killer Cell–Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors

22. Data from Nutlin-3a Enhances Natural Killer Cell–Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors

23. Supplementary Table 4. from Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway

24. Supplementary Table 3. from Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway

25. Supplementary Table 1. from Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway

26. Supplementary Table 2. from Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway

27. Data from Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway

28. Supplementary Figure legend from Nutlin-3a Enhances Natural Killer Cell–Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors

29. Supplementary Figure 1. Immunomodulatory ligands on melanoma cells. from Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway

30. Overall survival of patients stratified for CCL19 serum concentration. from Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway

31. Supplementary Table 1 from Nutlin-3a Enhances Natural Killer Cell–Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors

32. CSCs characterization. from Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway

34. Table S2 from NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines

35. The learning process: key phases and elements

36. Supplementary Table S1 from Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity

37. Supplementary Figure S4 from Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity

38. Data from Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity

39. Figures S1-S13 from NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines

40. Supplementary Table S2 from Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity

41. Table S3 from NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines

42. Supplementary Figure S1 from Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity

43. Supplementary Figure S3 from Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity

44. Supplementary Figure S2 from Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity

45. Supplementary Table and Figure Legends from Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity

46. Table S1 from NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines

47. SI Materials and Methods from NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines

48. Supplementary Methods, Table 1, Figure Legends 1-7 from Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity

Catalog

Books, media, physical & digital resources